LEHI, Utah / Mar 01, 2023 / Business Wire / Owlet, Inc. (“Owlet”) (NYSE: OWLT) today announced that it will participate in the Cowen 43rd Annual Health Care Conference taking place on March 6-8, 2023 at the Boston Marriott Copley Place in Boston, Massachusetts. Kurt Workman, Owlet’s Co-Founder, President and Chief Executive Officer, and Kate Scolnick, Chief Financial Officer, are scheduled to present at the conference on Tuesday, March 7 at 1:30 p.m. EST. A link to the live webcast of the fireside chat will be available on the Owlet Investor Relations website, investors.owletcare.com. A replay of the webcast will also be available on Owlet’s Investor Relations website.
About Owlet, Inc.
Owlet was founded by a team of parents in 2012. Owlet’s mission is to empower parents with the right information at the right time, to give them more peace of mind and help them find more joy in the journey of parenting. Owlet’s digital parenting platform aims to give parents real-time data and insights to help parents feel more calm and confident. Owlet believes that every parent deserves peace of mind and the opportunity to feel their well-rested best. To learn more, visit www.owletcare.com.
| Last Trade: | US$8.02 |
| Daily Change: | -0.01 -0.12 |
| Daily Volume: | 27,481 |
| Market Cap: | US$132.490M |
May 08, 2025 March 04, 2025 January 28, 2025 September 13, 2024 September 11, 2024 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
